Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Express Scripts
Boehringer Ingelheim
AstraZeneca
Mallinckrodt

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,174,442

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,174,442
Title: Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent
Abstract:An adsorbent for phosphate from aqueous medium, particularly for inorganic phosphate or phosphate bound to foodstuffs from body fluids or foodstuffs, which contains beta-iron hydroxide stabilized by carbohydrates and/or by humic acid.
Inventor(s): Geisser; Peter (St. Gallen, CH), Philipp; Erik (St. Gallen, CH)
Assignee: Vifor (International) AG (St. Gallen, SE)
Application Number:09/077,944
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,174,442
Patent Claim Types:
see list of patent claims
Compound; Process; Formulation;

Drugs Protected by US Patent 6,174,442

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vifor Fresenius VELPHORO sucroferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes   Start Trial   Start Trial Y CONTROL OF PHOSPHOROUS LEVELS IN PATIENTS   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,174,442

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany195 47 356Dec 19, 1995
PCT Information
PCT FiledDecember 19, 1996PCT Application Number:PCT/EP96/05695
PCT Publication Date:June 26, 1997PCT Publication Number: WO97/22266

International Family Members for US Patent 6,174,442

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 005026   Start Trial
Austria 207707   Start Trial
Australia 1374797   Start Trial
Brazil 9612138   Start Trial
Canada 2240668   Start Trial
Germany 19547356   Start Trial
Germany 59608089   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Merck
McKinsey
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.